LYNDHURST, N.J., June 28 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Robert A. Hagemann, Senior Vice
President and Chief Financial Officer, is scheduled to speak at the Wachovia
Securities Fifteenth Annual Nantucket Equity Conference on, Wednesday, June
29, 2005, at Harbor House Village, in Nantucket, Massachusetts. The Quest
Diagnostics presentation is scheduled to begin at 2:00 p.m. Eastern Time.
The presentation will be webcast live during the conference and will be
available to registered investors on the following site:
http://www.wsw.com/webcast/wa28/dgx and to the public on
http://www.questdiagnostics.com . In addition, the archived webcast will be
available immediately after the presentation for 30 days.
Quest Diagnostics is the leading provider of diagnostic testing,
information and services that patients and doctors need to make better
healthcare decisions. The company offers the broadest access to diagnostic
testing services through its national network of laboratories and patient
service centers, and provides interpretive consultation through its extensive
medical and scientific staff. Quest Diagnostics is a pioneer in developing
innovative new diagnostic tests and advanced healthcare information technology
solutions that help improve patient care. Additional company information is
available at: http://www.questdiagnostics.com .
The statements in this press release which are not historical facts or
information may be forward-looking statements. These forward-looking
statements involve risks and uncertainties that could cause actual results and
outcomes to be materially different. Certain of these risks and uncertainties
may include, but are not limited to, competitive environment, changes in
government regulations, changing relationships with customers, payers,
suppliers and strategic partners and other factors described in the Quest
Diagnostics Incorporated 2004 Form 10-K and subsequent filings.
SOURCE
Quest Diagnostics Incorporated 06/28/2005
CONTACT:
Laure Park, Investors
1-201-393-5030
or
Gary Samuels, Media,
1-201-393-5700
both for Quest Diagnostics Incorporated